231 related articles for article (PubMed ID: 18583470)
1. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
Eng-Wong J; Orzano-Birgani J; Chow CK; Venzon D; Yao J; Galbo CE; Zujewski JA; Prindiville S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1696-701. PubMed ID: 18583470
[TBL] [Abstract][Full Text] [Related]
2. RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
Howell A; Ashcroft L; Fallowfield L; Eccles DM; Eeles RA; Ward A; Brentnall AR; Dowsett M; Cuzick JM; Greenhalgh R; Boggis C; Motion J; Sergeant JC; Adams J; Evans DG
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):58-66. PubMed ID: 29097444
[No Abstract] [Full Text] [Related]
3. Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo.
Freedman M; San Martin J; O'Gorman J; Eckert S; Lippman ME; Lo SC; Walls EL; Zeng J
J Natl Cancer Inst; 2001 Jan; 93(1):51-6. PubMed ID: 11136842
[TBL] [Abstract][Full Text] [Related]
4. Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years.
Brentnall AR; Warren R; Harkness EF; Astley SM; Wiseman J; Fox J; Fox L; Eriksson M; Hall P; Cuzick J; Evans DG; Howell A
Breast Cancer Res; 2020 Sep; 22(1):101. PubMed ID: 32993747
[TBL] [Abstract][Full Text] [Related]
5. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation.
Cauley JA; Norton L; Lippman ME; Eckert S; Krueger KA; Purdie DW; Farrerons J; Karasik A; Mellstrom D; Ng KW; Stepan JJ; Powles TJ; Morrow M; Costa A; Silfen SL; Walls EL; Schmitt H; Muchmore DB; Jordan VC; Ste-Marie LG
Breast Cancer Res Treat; 2001 Jan; 65(2):125-34. PubMed ID: 11261828
[TBL] [Abstract][Full Text] [Related]
6. Correlation between mammographic density and volumetric fibroglandular tissue estimated on breast MR images.
Wei J; Chan HP; Helvie MA; Roubidoux MA; Sahiner B; Hadjiiski LM; Zhou C; Paquerault S; Chenevert T; Goodsitt MM
Med Phys; 2004 Apr; 31(4):933-42. PubMed ID: 15125012
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer.
Eng-Wong J; Reynolds JC; Venzon D; Liewehr D; Gantz S; Danforth D; Liu ET; Chow C; Zujewski J
J Clin Endocrinol Metab; 2006 Oct; 91(10):3941-6. PubMed ID: 16868059
[TBL] [Abstract][Full Text] [Related]
8. Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR).
Cecchini RS; Costantino JP; Cauley JA; Cronin WM; Wickerham DL; Bandos H; Weissfeld JL; Wolmark N
Cancer Prev Res (Phila); 2012 Nov; 5(11):1321-9. PubMed ID: 23060039
[TBL] [Abstract][Full Text] [Related]
9. Gynecologic and hormonal effects of raloxifene in premenopausal women.
Premkumar A; Venzon DJ; Avila N; Johnson DV; Remaley AT; Forman MR; Eng-Wong J; Zujewski J; Stratton P
Fertil Steril; 2007 Dec; 88(6):1637-44. PubMed ID: 17662283
[TBL] [Abstract][Full Text] [Related]
10. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.
Thompson DJ; Leach MO; Kwan-Lim G; Gayther SA; Ramus SJ; Warsi I; Lennard F; Khazen M; Bryant E; Reed S; Boggis CR; Evans DG; Eeles RA; Easton DF; Warren RM;
Breast Cancer Res; 2009; 11(6):R80. PubMed ID: 19903338
[TBL] [Abstract][Full Text] [Related]
11. Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women.
Iversen A; Frydenberg H; Furberg AS; Flote VG; Finstad SE; McTiernan A; Ursin G; Wilsgaard T; Ellison PT; Jasienska G; Thune I
Eur J Cancer Prev; 2016 Jan; 25(1):9-18. PubMed ID: 25714648
[TBL] [Abstract][Full Text] [Related]
12. Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
Kim EY; Chang Y; Ahn J; Yun JS; Park YL; Park CH; Shin H; Ryu S
Cancer; 2020 Nov; 126(21):4687-4696. PubMed ID: 32767699
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mammographic density among women with a strong family history of breast cancer.
Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.
Salazar AS; Rakhmankulova M; Simon LE; Toriola AT
JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33554041
[TBL] [Abstract][Full Text] [Related]
16. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
[TBL] [Abstract][Full Text] [Related]
17. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women.
Jackson VP; San Martin JA; Secrest RJ; McNabb M; Carranza-Lira S; Figueroa-Casas P; Fernandes CE; Romaguera J
Am J Obstet Gynecol; 2003 Feb; 188(2):389-94. PubMed ID: 12592245
[TBL] [Abstract][Full Text] [Related]
19. Adolescent intake of animal fat and red meat in relation to premenopausal mammographic density.
Bertrand KA; Burian RA; Eliassen AH; Willett WC; Tamimi RM
Breast Cancer Res Treat; 2016 Jan; 155(2):385-93. PubMed ID: 26791521
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
Zujewski J
Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
